Katsiampoura A, Raghav K, Jiang ZQ, Menter DG, Varkaris A, Morelli MP, Manuel S, Wu J, Sorokin AV, Rizi BS, Bristow C, Tian F, Airhart S, Cheng M, Broom BM, Morris J, Overman MJ, Powis G, Kopetz S
Notably, the extent of weight loss achieved with GLP-1 RA therapy may be directly linked to the degree of reduction in preference for high-calorie foods as semaglutide was associated with reduced cravings for both savory and sugary foods, with decreases in craving scores correlating with greater weight loss (Wharton et al., 2023) which persisted for up to 2 years (Wharton et al., 2023)
Pevec, D., Kralj, T., Kljusuric, J
doi: 10.1002/ptr.2667 449 AbdelgawadSMHettaMHIbrahimMABalachandranPZhangJWangMet al
Where real-world stories meet the science The New York Times essay described the use of GLP-1s as a kind of large-scale real-world experiment
Its active ingredients are obtained through the bio-fermentation process and from 100% natural (not synthetic, that is made in a laboratory) sources